Meet Real Patients With Severe Plaque Psoriasis
Through the following stories, you can share in the experiences of real people who are living with severe plaque psoriasis. Their stories are representative of patients who are responding to REMICADE® under physician supervision.
Each of these stories can help you understand:
- How severe plaque psoriasis has affected other people's lives
- How other people came to be diagnosed and treated for severe plaque psoriasis
- How REMICADE® can relieve the symptoms caused by severe plaque psoriasis
COLLEEN'S STORY Read more Hide story
“I know there's no cure for plaque psoriasis. But for me, REMICADE® made a big difference.”
Colleen has lived with plaque psoriasis since she was in college. After years of struggling with severe plaque psoriasis, she finally got the results she was looking for with REMICADE®.
Living with plaque psoriasis
“I tried lots of treatments over the years—creams, pills, light therapy. Nothing worked. So I just did my best to conceal the problem: long pants, long sleeves, light colors. Going to the beach wasn't fun for me at all. If I did go, I went into the water wearing a towel over my bathing suit and would have a friend take the towel back to shore so no one else would see my skin.”
Results with REMICADE®
“My mom told me about REMICADE®—a treatment that was working well for many people. So I talked to my dermatologist, and we decided it was the right medication for me. Well, I started to see results after just 2 weeks. And within 2 months, my skin was much clearer. And for the first time in 17 years, I could wear shorts and enjoy my summer.”
My life with REMICADE®
“I know there's no cure for plaque psoriasis. But for me, REMICADE® made a big difference. Now I get a treatment every 2 months. I don't need my creams anymore—1 year later and my skin is still much clearer.”
Colleen is representative of patients responding to therapy with REMICADE® under a physician's supervision. Individual results may vary.
MICHAEL'S STORY Read more Hide story
“I learned about REMICADE®. After just 2 weeks of treatment with REMICADE®, I started to see a difference.”
“I was tired of always having to explain myself and be on the defensive.”
Michael has lived with plaque psoriasis since he was a young child. After years of struggling with severe plaque psoriasis, he finally got the results he was looking for, as an adult, with REMICADE®.
Living with plaque psoriasis
“Throughout most of my life, I had to deal with having plaque psoriasis. At the same time, I had to deal with the misunderstandings of other people about my condition. For a while, it seemed I wasn't just Michael but ‘the guy with the skin disorder.’”
Getting diagnosed with plaque psoriasis
“When I was 4, I had a severe case of strep throat. Then I developed these red spots on my arms and legs. Shortly after that, I was diagnosed with psoriasis.”
Living with plaque psoriasis
“My mother always tried to explain to people that my plaque psoriasis wasn't contagious. She said it was like having really dry skin, not chicken pox. But that didn't always work. While I lived with the symptoms of plaque psoriasis, I was getting tired of always having to explain myself and be on the defensive. One time, I was working as a counselor at a summer camp. I covered up as much as I could, but one of the parents saw the plaque psoriasis on my elbow and asked to see a note from my doctor to prove none of the kids could ‘catch' my plaque psoriasis.”
Results with REMICADE®
“Finally, as an adult—and after many years of trying different treatments—I learned about REMICADE®. After just 2 weeks of treatment with REMICADE®, I saw a huge difference.”
My life with REMICADE®
“With the help of REMICADE®, people look at me and see me—Michael—not that guy with a skin disorder.”
Michael is representative of patients responding to therapy with REMICADE® under a physician's supervision. Individual results may vary.
REMICADE® is a prescription medication used to treat:Crohn's Disease
- Can reduce signs and symptoms and induce and maintain remission in adult patients with moderately to severely active Crohn’s disease who haven't responded well to other therapies
- Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active Crohn's disease who haven't responded well to other therapies
- Can reduce signs and symptoms, induce and maintain remission, promote intestinal healing, and reduce or stop the need for steroids in adult patients with moderately to severely active ulcerative colitis who haven't responded well to other therapies
- Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active ulcerative colitis who haven’t responded well to other therapies
- Can reduce signs and symptoms, help stop further joint damage, and improve physical function in patients with moderately to severely active rheumatoid arthritis, in combination with methotrexate
- Can reduce signs and symptoms of active arthritis, help stop further joint damage, and improve physical function in patients with psoriatic arthritis
- Can reduce signs and symptoms in patients with active ankylosing spondylitis
- Approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE® is appropriate considering other available therapies
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in teenage or young adult males with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.
You should discuss any concerns about your health and medical care with your doctor.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
- Tuberculosis (TB) or have been near someone who has TB. Your doctor will check you for TB with a skin test. If you have latent (inactive) TB, you will begin TB treatment before you start REMICADE®.
- Lived in a region where certain fungal infections like histoplasmosis or coccidioidomycosis are common.
- Infections that keep coming back, have diabetes or an immune system problem.
- Any type of cancer or a risk factor for developing cancer, for example, chronic obstructive pulmonary disease (COPD) or had phototherapy for psoriasis.
- Heart failure or any heart condition. Many people with heart failure should not take REMICADE®.
- Hepatitis B virus (HBV) infection or think you may be a carrier of HBV. Your doctor will test you for HBV.
- Nervous system disorders (like multiple sclerosis or Guillain-Barré syndrome).
Also tell your doctor if you:
- Use the medicines Kineret (anakinra), Orencia (abatacept) or Actemra (tocilizumab) or other medicines called biologics used to treat the same problems as REMICADE®.
- Are pregnant, plan to become pregnant, are breast-feeding, or have a baby and were using REMICADE® during your pregnancy. Tell your baby’s doctor about your REMICADE® use before the baby receives any vaccine because of an increased risk of infection for up to 6 months after your last dose of REMICADE® you received during your pregnancy.
- Recently received or are scheduled to receive a vaccine. Adults and children taking REMICADE® should not receive live vaccines or treatment with a weakened bacteria (such as BCG for bladder cancer) while taking REMICADE®.
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
- Infections (like TB, blood infections, pneumonia)—fever, tiredness, cough, flu, or warm, red or painful skin or any open sores. REMICADE® can make you more likely to get an infection or make any infection that you have worse.
- Lymphoma, or any other cancers in adults and children.
- Skin cancer—any changes in or growths on your skin.
- Heart failure—new or worsening symptoms, such as shortness of breath, swelling of your ankles or feet, or sudden weight gain.
- Reactivation of HBV—feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain.
- Liver injury—jaundice (yellow skin and eyes), dark brown urine, right-sided abdominal pain, fever, or severe tiredness.
- Blood disorders—fever that doesn’t go away, bruising, bleeding or severe paleness.
- Nervous system disorders—numbness, weakness, tingling, changes in your vision or seizures.
- Allergic reactions during or after the infusion—hives, difficulty breathing, chest pain, high or low blood pressure, swelling of face and hands, and fever or chills.
- Lupus-like syndrome—chest discomfort or pain that does not go away, shortness of breath, joint pain, rash on the cheeks or arms that gets worse in the sun.
- Psoriasis—new or worsening psoriasis such as red scaly patches or raised bumps on the skin that are filled with pus.
The more common side effects with REMICADE® are respiratory infections (that may include sinus infections and sore throat), headache, rash, coughing and stomach pain.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.